CLINICAL CENTERS FOR ETIOLOGY OF SARCOIDOSIS: A CASE CONTROL STUDY NIH GUIDE, Volume 23, Number 33, September 16, 1994 RFP AVAILABLE: NHLBI-HR-94-21 P.T. Keywords: National Heart, Lung, and Blood Institute The overall objective of this program is to support a six year multi-center case-control study on the potential etiologic factors for sarcoidosis. The program will be conducted in three Phases. Phase I (12 Months) will involve protocol development. Phase II (48 Months) will involve recruitment and follow-up. Phase III will involve data analysis and publication preparation. This program will consists of a clinical coordinating center and up to twelve clinical centers. The clinical centers will recruit 840 sarcoidosis patients and 1680 control subjects for study over a four year period. The cases will also be followed to gain information on the natural history of this disease including risk factors for progression of disease. The protocol to be developed during Phase I (12 Months) will include a comprehensive clinical characterization of each participant and determination of markers of immune responsiveness. Each clinical center will: (1) participate in a cooperative effort with other study investigators to develop and pretest data reporting forms; (2) establish and train staff to conduct the study; (3) enroll, interview, and examine 70 patients (age 21 years or older) with sarcoidosis and, enroll, interview and collect a blood specimen from 140 matched control subjects over a four year period; (4) shall have a patient population composition that will enable the investigators to address factors of gender and ethnicity that are hypothesized to play a role in the susceptibility to and expression of sarcoidosis; (5) document the diagnosis of sarcoidosis in recruited cases by standard clinical criteria, including histologic evidence of non-caseating granulomatous inflammation and exclusion of other diseases; (6) perform follow-up assessment on the patients; (7) assess progression of disease and use of medical care resources; (8) collect data and forward the data to the Clinical Coordinating Center; (9) participate in the biological banking system as managed by the Clinical Coordinating Center in collaboration with the NHLBI-supported repository; (10) work with other study investigators in the preparation and writing of reports and manuscripts for publication; (11) interact with the Clinical Coordinating Center to provide data and related information necessary for data analysis, and (12) work with other study investigators in the preparation and writing of reports and manuscripts for publication. This announcement is for clinical centers only. A separate Request for Proposals (RFP) for the clinical coordinating center will be released in the near future. This is not a request for proposals. It is anticipated that RFP NHLBI- HR-94-21 will be available on or about September 15, 1994, with proposals due on or about November 30, 1994. It is to be noted that award of a contract for this study shall be made only to offerors who are located in the United States of America. INQUIRIES Copies of the RFP may be obtained by submitting a written request along with three self-addressed mailing labels to: Joanne C. Deshler Contracts Operations Branch National Heart, Lung, and Blood Institute Westwood Building, Room 654 5333 Westbard Avenue Bethesda, MD 20892 .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |